SHANGHAI, Nov. 4, 2023 /PRNewswire/ — On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their independent R&D clinical trial application (IND) for KGX101. KGX101 is a recombinant IL-12 Fc fusion protein designed for intravenous injection. The KGX101 clinical trials will be carried out simultaneously in both United States … Read more
DALLAS, Nov. 3, 2023 /PRNewswire/ — Ironside Human Resources was named as Placeholder No. 7 last night during the Annual Dallas 100 Entrepreneur Awards Gala hosted by the SMU Cox School of Business. The gala took place at the Hyatt Regency in Dallas. Representatives from each of the recognized companies were present at the event. … Read more
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Healthcare Operational Analytics Market Size & Share Analysis – Growth Trends & Forecasts (2023 – 2028)” report has been added to ResearchAndMarkets.com’s offering. The global healthcare operational analytics market, estimated at USD 10.7 billion in 2022, is on track to achieve remarkable growth, projected to reach USD 22.4 … Read more
Updated data from the Phase I trial of RVU120 in relapsed/refractory acute myeloid leukemia (r/r AML) or high-risk myelodysplastic syndromes (HR-MDS) demonstrate clinically relevant benefit in 50% of evaluable patients Preclinical data support RVU120 as a novel agent for the treatment of patients with lower-risk MDS (LR-MDS) and show cytotoxic and differentiating effects on leukemic stem cells … Read more
DUBLIN, Nov. 1, 2023 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference on Tuesday, November 14, 2023 Fireside chat at 4:30 a.m. PT / 7:30 a.m. ET / 12:30 p.m. GMT 6th Annual Evercore ISI HealthCONx Conference on Tuesday, … Read more
DUBLIN, Oct. 31, 2023 /PRNewswire/ — The “Recombinant DNA Technology: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Recombinant DNA Technology estimated at US$64.7 Billion in the year 2022, is projected to reach a revised size of US$93.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period … Read more
NEW YORK, Oct. 31, 2023 /PRNewswire/ — The next-generation sequencing market size is forecast to increase by USD 3,409.76 million from 2022 to 2027, at a CAGR of 12.45%, according to the recent market study by Technavio. The growth of the market will be driven by the Increased utilization of NGS methods, Growing demand for early diagnosis of … Read more
ROCKVILLE, Md., Oct. 30, 2023 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Academy of Ophthalmology (AAO) 2023 Annual Meeting being held November 3-6, 2023 in San Francisco, CA. The presentations will highlight new data for ABBV-RGX-314, an investigational one-time AAV Therapeutic being developed in collaboration with AbbVie for the treatment … Read more
SHENZHEN, China, Oct. 29, 2023 /PRNewswire/ — The 88th China International Medical Equipment Fair (CMEF) officially kicks off on October 28 at the Shenzhen World Exhibition & Convention Center. The four-day tradeshow will feature over 10,000 products brought by over 4,000 exhibitors from more than 20 countries and regions worldwide. China International Medical Equipment Fair (CMEF) … Read more
INDIANAPOLIS, Oct. 28, 2023 /PRNewswire/ — The 16th annual CNO Financial Indianapolis Monumental Marathon, Half Marathon and 5K took place this morning in downtown Indianapolis in true monumental fashion, with nearly 15,000 athletes participating. The event was highlighted by three new course records and 19 athletes achieving the Olympic Team Trials – Marathon standard, unofficially. … Read more